Search
for
Sort by
Research 361–390 of 1000+
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- ADM Scaffolds Generate a Pro-regenerative Microenvironment During Full-Thickness Cutaneous Wound Healing Through M2 Macrophage Polarization via Lamtor1
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- 1379 Cell of origin contributes to the melanoma diversity
- Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report
- Neuroimmunology of Stress: Skin Takes Center Stage
- Therapeutic Effect of Rumex japonicus Houtt. on DNCB-Induced Atopic Dermatitis-Like Skin Lesions in Balb/c Mice and Human Keratinocyte HaCaT Cells
- Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- New insights into inflammatory memory of epidermal stem cells
- Mapping of cis-acting expression quantitative trait loci in human scalp hair follicles
- Anti-ageing effect of a lactococcal strain: analysis using senescence-accelerated mice
- Dermatophytosis in companion animals: A review
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Effects of Post-Therapy Changes on the Level of Immunoglobulin M in Dogs with Dermatitis
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor